Literature DB >> 20947300

Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review.

A Neligan1, S D Shorvon.   

Abstract

OBJECTIVES: to determine how the duration of SE, the EEG findings during/after SE, the depth of coma at presentation and age impact on the prognosis of convulsive status epilepticus indepedent of aetiology and to analyse the outcome of status epilepticus with respect to mortality and morbidity (the latter measured in terms of functional decline, cognitive/intellectual decline and the prospective risk of epilepsy).
DESIGN: a systematic review of all studies of status epilepticus (SE) with greater then 30 patients published from the 01/01/1990 up until 31/12/2009.
RESULTS: oveall the longer the duration of SE the worse the prognosis particularly after 1-2h of continuous seizures although this affect may be lost after 10h. The depth of coma correlates well with outcome. Only periodic epileptiform discharges (PEDs) have been shown to be associated with a poorer outcome in most (but not all) studies although this is probably related to the underlying aetiology. Age is an important prognostic factor with children having a better prognosis then adults.
CONCLUSIONS: age and depth of coma at presentation appear to be the strongest predictors of outcome of SE independent of aetiology with the duration of SE and the EEG findings less important. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20947300     DOI: 10.1016/j.eplepsyres.2010.09.003

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  30 in total

Review 1.  Management of refractory status epilepticus in adults: still more questions than answers.

Authors:  Andrea O Rossetti; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

2.  Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society.

Authors:  Tracy Glauser; Shlomo Shinnar; David Gloss; Brian Alldredge; Ravindra Arya; Jacquelyn Bainbridge; Mary Bare; Thomas Bleck; W Edwin Dodson; Lisa Garrity; Andy Jagoda; Daniel Lowenstein; John Pellock; James Riviello; Edward Sloan; David M Treiman
Journal:  Epilepsy Curr       Date:  2016 Jan-Feb       Impact factor: 7.500

Review 3.  Refractory and super-refractory status epilepticus--an update.

Authors:  Sara Hocker; William O Tatum; Suzette LaRoche; W David Freeman
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

Review 4.  Role of the calcium plateau in neuronal injury and behavioral morbidities following organophosphate intoxication.

Authors:  Laxmikant S Deshpande; Robert E Blair; Kristin F Phillips; Robert J DeLorenzo
Journal:  Ann N Y Acad Sci       Date:  2016-06-21       Impact factor: 5.691

Review 5.  [Emergency and intensive medical care of status epilepticus].

Authors:  A C Hoppner; W Klingler
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-04       Impact factor: 0.840

6.  Evaluation of a clinical tool for early etiology identification in status epilepticus.

Authors:  Jong Woo Lee; Andrea O Rossetti; Vincent Alvarez; M Brandon Westover; Frank W Drislane; Barbara A Dworetzky; David Curley
Journal:  Epilepsia       Date:  2014-11-10       Impact factor: 5.864

7.  Treatment deviating from guidelines does not influence status epilepticus prognosis.

Authors:  Andrea O Rossetti; Vincent Alvarez; Jean-Marie Januel; Bernard Burnand
Journal:  J Neurol       Date:  2012-08-17       Impact factor: 4.849

8.  Acute Resective Surgery for the Treatment of Refractory Status Epilepticus.

Authors:  Maysaa Merhi Basha; Kushak Suchdev; Monica Dhakar; William J Kupsky; Sandeep Mittal; Aashit K Shah
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

9.  Factors related to delays in pre-hospital management of status epilepticus.

Authors:  Leena Kämppi; Harri Mustonen; Seppo Soinila
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

10.  Analysis of the delay components in the treatment of status epilepticus.

Authors:  Leena Kämppi; Harri Mustonen; Seppo Soinila
Journal:  Neurocrit Care       Date:  2013-08       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.